Financial Partners Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Financial Partners Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,351	Closed	-$5.89M	–	99
2017 Q4	$5.89M	Sell	69,351 -215	-0.3%	-$18K	1.09%	36
2017 Q3	$6.02M	Sell	69,566 -2,025	-3%	-$162K	1.15%	36
2017 Q2	$5.53M	Buy	71,591 +4,115	+6%	+$292K	1.15%	36
2017 Q1	$4.68M	Buy	67,476 +32,195	+91%	+$2.16M	1.03%	41
2016 Q4	$2.09M	Sell	35,281 -18,679	-35%	-$1.15M	0.5%	56
2016 Q3	$3.23M	Buy	+53,960	New	+$3.34M	0.82%	48

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Partners Capital Management's XBI Position: Q1 2018 in Review

Financial Partners Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2018, closing a stake of 69,351 shares — an estimated $5.89M sold.

Financial Partners Capital Management first reported a position in XBI in Q3 2016 and held it in 6 quarters. The position peaked at $6.02M in Q3 2017. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

Financial Partners Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2018 after selling out during the quarter.
Financial Partners Capital Management sold 69,351 State Street SPDR S&P Biotech ETF shares in Q1 2018, an estimated $5.89M.
Financial Partners Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 6 quarters.
Financial Partners Capital Management's State Street SPDR S&P Biotech ETF position peaked at $6.02M in Q3 2017.
414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on Financial Partners Capital Management's 13F filing for Q1 2018, filed 18 May 2018.